ABSTRACT Muntingia, or Jamaica Cherry, is a small, fast---growing tree that can reach up to 40 ft. tall at full maturity. The soft leaves are evergreen and have an alternate phyllotaxy. Leaves are dark green on top and light green underneath. The small, white flowers feature yellow stamens in the center. The small, round fruits are abundant, and depending on the variety, have a red or yellow color. Fruits are edible raw or made into jam. The fruit possessed potent anti-inflammatory activity. The flowers have antiseptic and antispasmodic qualities, and are made into medicinal teas. The M. calabura leaves exhibited potential anti-proliferative and antioxidant activities. The present study on Muntingia is to give an overview on traditional uses and pharmacological activity.
INTRODUCTION
There has been an increased urgency to discover novel antibiotics/anti microbial compounds due to emergence of drug resistant microorganisms. Therefore, an infection caused by antibiotic resistant microbes complicates conventional treatment causing prolonged illness and increases the death risks. Many medical practitioners also employ traditional (Ayurvedic) medicine, in Western and other developing nations like India, in complementary to modern medicines. Today also, as a testament to its persistence, over 80% of people in the world still utilize traditional medicine for primary healthcare. Many underdeveloped countries are rich in biodiversity hotspots like Southeast Asia, Africa, Central and Southern America. Among all the natural resources, plants are the single largest source for traditional medicines, accounting for 25% of new drugs components being tested for clinical trials (Singh et al.,2017) .
Cherry leaves (Muntingia calabura) contain antioxidants that generally form by phenolic or pholifenols, the sinamat acid derivatives, flavonoids, tocopherols, coumarin and polifungsional acids. Flavonoids that have an antioxidant activity consist of flavonol, flavanon, flavones, isoflavones, catechins and kalkon. Phenolic compounds that have antioxidant activity can be known through the way of extraction. Extractions are a way to separate a desired substance when it is mixed with others. The mixture is brought into contact with a solvent in which the substance of interest is soluble, but the other substances present are insoluble. Components of active compounds from plants or animals can be extracted based on "Like Dissolved Like Theory", compounds will be extracted depends on solubility (Triswaningsih et al.,2017) .
Medicinal plants are sources of important therapeutic aid for alleviating human ailments. Approximately 80% of the people in the developing countries all over the world depend on the traditional medicine for their primary health-care. Interestingly, approximately 85% of traditional medicine involves the use of plant extracts. Interest in phytomedicine started in the last 20 years and with increasing awareness of the health hazards and toxicities associated with unsystematic use of synthetic drugs and antibiotics, interest in the use of plants and plant-based drugs has revived throughout the world. However, a large number of medicinal plants remain to be investigated for their possible pharmacological value. One of the plants that has recently gained a medicinal plant status is Muntingia calabura L. (Elaeocarpaceae).
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ORIGIN AND DISTRIBUTION :
The Jamaica cherry is indigenous to southern Mexico, Central America, tropical South America, the Greater Antilles, St. Vincent and Trinidad. The type specimen was collected in Jamaica. It is widely cultivated in warm areas of the New World and in India, south-east Asia, Malaya, Indonesia, and the Philippines, in many places so thoroughly naturalized that it is thought by the local people to be native. The fruits are sold in Mexican markets. In Brazil, they are considered too small to be of commercial value but it is recommended that the tree be planted on river banks so that the abundance of flowers and fruits falling into the water will serve as bait, attracting fish for the benefit of fishermen. In Malaya, the tree is considered a nuisance in the home garden because fruit-bats consume the fruits and then spend the day under the eaves of houses and disfigure the porch and terrace with their pink, seedy droppings.
MEDICINAL USES
Antioxidant activity, improvement in endothelial function, vascular function and insulin sensitivity; as well as attenuation of platelet reactivity and reduction in blood pressure. Moreover proper scientific screening of potential bio actives of these plants followed by chemical investigations is necessary to make these herbal remedies more viable. In this context, the present study was undertaken to evaluate the antioxidant of Muntingia calabura(raw fruit).
TRADITIONAL USES :
The This might explain why M. calabura medicinal value is not well documented in Malaysia and why it is considered as a neglected plant. Despite the lack of traditional claims, various parts of the plant have been used to treat different types of illnesses. In Peruvian folklore medicine, the flowers and barks are used as an antiseptic and to reduce swelling in lower extremities while the leaves, either boiled or steeped in water, are used to reduce gastric ulcer and swelling of prostate gland, and to alleviate headache and cold. Moreover, the boiled barks can be used as a wash to reduce swelling in the lower extremities. In Colombia, the infusion of the flowers is used as a tranquillizer and tonic. In Mexico, the plant is used to treat measles, mouth pimples and stomach ache. In Philippines, the flowers is also used to treat headache and incipient cold or as tranquillizers, antispasmodics and antidyspeptics. Other than that, the roots of M. calabura have been used as an emmenogogue in Vietnam and as an abortifacient in Malaysia.
Other than for medicinal uses, the fruit, which are sometimes eaten fresh, are frequently cooked in tarts or made into jam, while the leaf infusion is drunk as a tea-like beverage.
OTHER USES:
Wood: The sapwood is yellowish, the heartwood red-dish-brown, firm, compact, fine-grained, moderately strong, light in weight, durable indoors, easily worked, and useful for interior sheathing, small boxes, casks, and general carpentry. It is valued mostly as fuel, for it ignites quickly, burns with intense heat and gives off very little smoke. Jamaicans seek out trees blown down by storms, let them dry for a while and then cut them up, preferring this to any other wood for cooking. It is being evaluated in Brazil as a source of paper pulp. Bark: The bark is commonly used for lashing together the supports of rural houses. It yields a very strong, soft fiber for twine and large ropes.
Medicinal Uses: The flowers are said to possess antiseptic properties. An infusion of the flowers is valued as an antispasmodic. It is taken to relieve headache and the first symptoms of a cold. 
CHEMICAL CONSTITUENTS OF M. calabura
-hexamethoxy-5ʹ,5ʹʹʹ-biflavan (11) and 8,5ʹ-dihydroxy-7,3ʹ,4ʹ-trimethoxyflavone (12) (Consolacion et al.,2015) .
PHARMACOLOGICAL ACTIVITIES AND CLINICAL TRIALS Antibacterial activity
The first attempt to study the antibacterial activity of M. calabura was carried out by using the leaves and fruits collected in the State of Puebla and State of Veracruz, Mexico. The MEMCL and methanol extract of M. calabura fruits (MEMCFr) diluted in 100 mg/mL of DMSO concentration were subjected to two-fold serial dilutions and then tested against Escherichia coli (C600) and Staphylococcus aureus (209 P) using the micro-dilution assay. Both MEMCL and MEMCFr exhibited antibacterial activity against E. coli and S. aureus with the recorded MIC of 512 and 1024 mg/mL, and 128 and 256 mg/mL, respectively. This was followed by another antibacterial activity report by Zakaria et al. (2007b) (Consolacion et al.,2015) .
M. calabura as Insecticidal activity
Only one study related to investigation of insecticidal activity of M. calabura was recorded using the flowers and fruits collected from the Universidade Rural Federal de Pernambuco (UFRPE), Recife, Brazil. The authors prepared two types of extracts from M. calabura flowers and fruits, namely ethanol extracts [flowers (EEMCFl) and fruits (EEMCFr)], and hexane extracts [flowers (HEMCFl) and fruits (HEMCFr)], at concentrations ranging from 0.25 to 30.0 mg/mL, and tested them against Plutella xylostella larvae and pupae using leaf disc immersion assay. All extracts were reported to be toxic to the larvae and pupae of P. xylostella. Moreover, the EEMCFl and EEMCFr were the most toxic against first instar P. xylostella larvae with the recorded LC50 of 0.61 mg/mL and 1.63 mg/mL, respectively. This is followed by the HEMCFr (LC50¼5.5 mg/mL) and HEMCFl (LC50¼18.9 mg/mL). When comparing their relative toxicities, it is worth highlighting that EEMCFl was 31.0-foldmore toxic than HEMCFl, and 4.2 -and 8.9-fold more toxic than EEMCFr and HEMCFr, respectively. Overall, these extracts were more effective than cordycepin, the reference drug, which produced 100% mortality only at 500 mg/mL in 72 h (Zakaria et al., 2010) .
Anti-nociceptive activity
The first attempt to investigate the antinociceptive activity of M. calabura was made using the leaves collected from Shah Alam, Selangor, Malaysia, between January and February, 2004, AEMCL was prepared in concentrations of 10, 50, and 100% strength that is equivalent to 27, 135, and 270 mg/kg, was subjected to the acetic acid induced abdominal constriction test followed by another studies to determine the role of L-arginine/nitric oxide/cyclic-guanosine monophosphate (Largentine/NO/cGMP)pathway in the observed antinociceptive activity of AEMCL. concentration-dependent antinociceptive activity when assessed using the abdominal constriction test. Pre-treatment with L-arginine significantly blocked the antinociceptive activity of the extract at the highest concentration while pretreatment with NGnitro-L-arginine methyl esters (L-NAME) significantly enhances the antinociceptive effects at low, concentration but inhibit its effect at higher concentration ofAEMCL. Methylene blue (MB) significantly enhanced AEMCL antinociceptive activity at all concentrations used. Co-treatment of Larginine with L-NAME or MB together significantly reversed the antinociceptive activity of AEMCL at low concentration without affecting other concentrations of the AEMCL. These findings suggested the involvement of Larginine/NO/cGMP pathway in modulating the antinociceptive activity of AEMCL. Acetylsalicylic acid (ASA), in the dose of10 mg/kg, was used as the reference drug (Zakaria et al., 2007) . A year later, another report on the antinociceptive activity of M. calabura leaves was released. This time, the leaves were collected between July and August, 2005 from Shah Alam, Selangor, Malaysia, and prepared as CEMCL, in the concentrations of 10, 50, and 100% strength. CEMCL was tested for its antinociceptive activity using the abdominal constriction test, the hot plate test, and the formalin test. In the abdominal constriction test, the extract exhibited a concentration-dependent activity with CEMCL at the highest concentration producing 495% analgesia while CEMCL at 50% concentration produced an activity that was equieffective to that of 100 mg/kg ASA (the reference drug).The extract also exerted an antinociceptive effect, but in aconcentration-independent manner, when assessed using the hot plate test with the onset of activity depending on the concentration of CEMCL. However, the activity exerted by CEMCL, at all concentrations used, was overshadowed by the activity exhibited by 5 mg/kg morphine. The extract also demonstrated antinociceptive activity when assessed using the formalin test, which was seen in both early and late phases of the test. However, the concentrationdependent activity by CEMCL was observed only in the early phase of the formalin test. The reference drugs used in the formalin test were 5 mg/kg morphine for the early and late phase, and 100 mg/kg ASA, for the late phase (Preethi et al.,2011) .
Anti-inflammatory activity
The leaves were prepared as CEMCL, in the concentrations of 10, 50, and 100%, and tested using the carrageenan-induced paw edema test. ASA (100 mg/kg) was used as a reference drug. All concentrations of CEMCL exerted an inconsistent anti-inflammatory activity that was less effective than the ASA. Another report on the antiinflammatory activity of M. calabura leaves was also published while attempting to determine the antinociceptive activity of AEMCL. In this study AEMCL was prepared in the concentrations of 10, 50, and 100% (equivalent to the doses of 27, 135, and 270 mg/kg, respectively) and subjected to the carrageenan-induced paw edema assay. The results obtained demonstrated that the extract exhibited concentration-independent anti-inflammatory activity. The anti-inflammatory activity of the 10 and 50% AEMCL were completely lost after 7 h of its administration while the anti-inflammatory activity of 100% AEMCL was lost after only 6 h of its administration. It is worth mentioning that the antiinflammatory activity of AEMCL, at the concentrations of 10 and 50%, was significantly greater than the reference drug, 100 mg/kg ASA, at the interval of 3 and 4 h after their administration. In the recent attempt to study the pharmacological properties of the fruits of M. calabura, the MEMCFr and AEMCFr were prepared in doses of 200 and 400 mg/kg and tested using the carrageenan-induced paw edema test (Preethi et al., 2012a) . The results obtained demonstrated that both extracts exerted dose-dependent inhibition of carrageenan induced localized edema at 4 h after the administration of extracts. The significant anti-inflammatory activity was recorded at 24.5 and 44.2% for both doses of MEMCFr and at 20.4 and 46.2% for both doses of AEMCFr. Indomethacin, in the dose of 10 mg/kg, was used as the reference drug and caused 84.3% inhibition of carrageenan-induced edema formation in comparison with the extracts .
Antipyretic activity
The first attempt to determine the antipyretic potential of M. calabura was made by using the leaves that was prepared as CEMCL. The extract, at the concentrations of 10, 50, and 100%, was tested using extract exhibited a concentration-independent antipyretic activity. Comparison made against the 100 mg/kg ASA, as the reference drug, showed that the CEMCL antipyretic activity was less effective than the drug. Another report on the antipyretic activity of another extract of M. calabura, namely AEMCL, while studying the antinociceptive and antiinflammatory activities. The AEMCL exerted a concentration-independent antipyretic effect with the onset of effects of 27 and 135 mg/ kg AEMCL was recorded after 240 min of their administration. Overall, the antipyretic activity of AEMCL was less effective than the reference drug, 100 mg/kg ASA (Preethi et al., 2010) .
Antiulcer activity
The investigation of antiulcer potential of M. calabura was initiated with one study. This preliminary study was carried out by involving the use of M. calabura leaves obtained from a company, Ethno Resources Sdn. Bhd., Selangor, Malaysia. The leaves were prepared as EEMCL, in the dose of 250 and 500 mg/kg, and assayed only against the ethanol-induced gastric ulcer model. The extract demonstrated significant and dose-dependent antiulcer activity indicated by the reduction in the areas of gastric ulcer injuries (112.5±2.11 and 95.08±2.18mm2) in comparison with the negative control group (735.25± 2.12mm2) and 20 mg/kg omeprazole-treated group (the reference drug; 90.33±2.02mm2). Further study on the ethanoltreated stomach samples revealed that the EEMCL reduces the acidity of gastric content while increases the mucus production of gastric mucosa when compared with the negative control. Moreover, the subsequent microscopic observations supported the macroscopic findings. Another study on the antiulcer potential of M. calabura leaves was studied. In this study, the leaves were prepared as MEMCL and subjected to ethanol-and indomethacin-induced gastric ulcers wherein in the former assay the doses of 25, 50, 100, 250, and 500 mg/ kg were used while in the later assay, the doses of 100, 250, ad 500 mg/kg were used. The discrepancy in the range of doses used was attributed to preliminary findings using the ethanol-induced gastric ulcer model wherein the extract exerted a dose-independent antiulcer activity. Therefore, an additional study using lower doses (25 and 50 mg/kg) was performed (Sridhar et al., 2011) . Moreover, the role of NO and sulfhydryl groups in mediating the antiulcer activity of MEMCL was also investigated using the ethanolinduced gastric ulcer. From the results obtained, MEMCL, at all doses tested, exhibited a significant and dose-dependent reduction of ethanol-induced gastric ulcer formation with the percentage of antiulcer ranging between 63 and 95% in comparison with the reference drug, 100 mg/kg ranitidine, that produced 70% protection. In addition, all doses of MEMCL exerted significant and dose dependent inhibition of indomethacin-induced gastric ulcer formation with the percentage of protection ranging between 47 and 69%. In comparison, 100 mg/kg ranitidine exhibited 78% antiulcer activity. Histopathological evaluation revealed the extract potential to reverse the toxic effect of ethanol and indomethacin and returned the stomach to almost normal mucosal architecture that is comparable with protection exerted by ranitidine. Moreover, pretreatment with 70 mg/ kg L-NAME significantly worsened the gastric ulcers in MEMCL-and 100 mg/kg carbenoxolone-treated groups and this unwanted effect of L-NAME was reversed by 200 mg/kg L-arginine. These findings indicate the participation of NO in the antiulcer potential exerted by MEMCL. Pre-treatment with 10 mg/kg NEM, in contrast, significantly reversed the antiulcer activity of MEMCL and increased the gastric ulcer formation in comparison with saline pretreated group that is also receiving MEMCL. These findings indicate the participation of endogenous sulfhydryl compounds in the gastroprotective activity demonstrated by MEMCL (Sani et al., 2012) .
Antidiabetic activity
The leaves of M. calabura, collected from Station Ghanpur, Warangal, Andhra Pradesh, India, were prepared as MEMCL, in doses of 300 and 500 mg/kg, and subjected to the antidiabetic studies. Firstly, the serum glucose level was observed at 2, 4, 6, and 8 h after the administration of the extract. The results showed that both doses of MEMCL produced significant hypoglycemic effects after 6 and 4-8 h, respectively, in the normal fasted rats. significant reduction in the blood glucose level after 2 h of administration that lasted for another 6 h. In the second study, the effect of 500 mg/kg MEMCL on the oral glucose tolerance test (OGTT) was also investigated. The results showed that pre-treatment with 500 mg/kg MEMCL caused significant reduction in the rise of blood glucose at 1 h interval (116.46±6.94 mg/dL) when compared with the control group pre-treated with 5% gum acacia, which showed a rapid increase of blood glucose (144.73± 7.86 mg/dL). For the standard group (glipizide 5 mg/kg), the glucose levels reached the fasting values at the end of 1 h interval (72.09±2.98 mg/dL). In the third study, the 500 mg/ kg MEMCL was subjected to the alloxan-induced diabetic assay. Following the experiments, 500 mg/kg of MEMCL significantly reduced the alloxan-induced hyperglycemia with maximum effect observed at 6 h (27%) in comparison with the reference drug, 5 mg/kg glipizide, which produced 37% reduction in blood glucose level .
Antihypertensive activity
The leaves of M. calabura were collected in June, 2001, from Kaohsiung City, Taiwan and prepared as a methanol extract (MEMCL). The crude MEMCL was then partitioned using dH2O and chloroform in the ratio of 1:1, and the aqueous fraction obtained was further fractionated sequentially using a mixture of dH2O and n-butanol (1:1). The water-soluble fraction (WSF) was collected, prepared in the dose range of 10, 25, 50, 75, and 100 mg/kg, and systemically injected into the femoral vein of the animals. In the first study, the mean systemic arterial pressure (MSAP), heart rate (HR), baseline blood pH, gas (partial pressure of CO2 and O2), and electrolytes (Na+, K+, hematocrit) were measured for 3 h from blood samples withdrawn from the arterial blood following pre-treatment with isotonic normal saline, 5 mg/kg acetylcholine (the reference drug), or WSF (10, 25, 50, 75, or 100 mg/kg). In the second study, the plasma nitrate level was measured using blood samples withdrawn from the femoral artery using the chemiluminescense assay . In the third study, the biochemical analysis involving protein extraction and Western blot analysis were carried out. The apical heart or segment of thoracic aorta was rapidly removed from sacrificed rats and later subjected to Western blot analysis of iNOS, eNOS, nNOS, or b-actin protein.
Another study was performed to delineate the causative relationship between NO and M. calabura-induced cardiovascular responses wherein the temporal change in MSAP or HR elicited by 50 mg/kg WSF was measured for 180 min in rats subjected to pretreatment with L-NAME, L-NIO, SMT, 7-NI, or ODQ administered 20 min prior to administration of WSF. The findings revealed that intravenous administrations of WSF significantly and dose dependently caused an immediate decrease in MSAP (initial phase) that returned to the preinjection baseline within 10 min post-injection without affecting the HR. The decrease in MSAP was followed by a delayed hypotensive effect (delayed phase) that started at 90 min and lasted for approximately 180 min post-injection. Acetylcholine (5 mg/kg) also caused a significant decrease in MSAP that reached its peak within the first 30 s and lasted for less than 5 min post-administration. The authors also reported that treatment with a 50 mg/kg WSF caused no significant change to the baseline systemic arterial blood gases, electrolytes, Hct, and pH when measured at 10, 30, 60, 120, and 180 min postinjection as seen with saline and WSF, at the doses of 25, 75, and 100 mg/kg. Moreover, intravenous pretreatment with 0.65 mg/kg/min, as well as 0.13 and 0.35 mg/ kg/min L-NAME, a non-selective NOS inhibitor, significantly attenuated both the initial and delayed phases of hypotension induced by the WSF.
[16] An inhibitor of eNOS, L-NIO, given intravenously at the dose of 1.0 mg/kg/min, significantly suppressed only the initial phase of WSF-induced hypotension while, to the contrary, 0.5 mg/kg/min SMT, a selective inhibitor of iNOS, given through the same route strongly inhibited only the delayed phase of the same response. Of all doses of L-NAME, L-NIO, 7-NI or SMT used, only L-NMAE, at the highest dose (0.65 mg/kg/min), given alone evoked a significant and transient increase in MSAP by 12% and a decrease in HR by 11%. In addition, 0.2 mg/kg/min ODQ, an sGC inhibitor that had no significant effect on baseline MSAP or HR when given alone, markedly suppressed both the initial and delayed phases of WSF-decreased MSAP. WSF also induced a significant increase in iNOS, but not eNO or nNOS, protein expression in the heart or aorta detected at 90 or 180 min post-administration .
